Human erythropoietin improves blood plasma phospholipids concentration in chronically hemodialyzed patients.
نویسندگان
چکیده
Human Erythropoietin Improves Blood Plasma Phospholipids Concentration in Chronically Hemodialyzed Patients W. Wojciech Krawczyk A. Andrzej Ledwożyw A. Anna Dmoszyńska K. Krzysztof Marczewski Department of Internal Medicine and Dialysis Unit, Regional Hospital, Chetm, Department of Pathophysiology, Agricultural Academy, Department of Hematology, Medical School, Institute of Agricultural Medicine, Lublin, Poland
منابع مشابه
Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.
Recombinant human erythropoietin therapy was given to 15 patients undergoing long-term hemodialysis with normal cardiac function. None of the patients had hypertension before the erythropoietin therapy and had received no antihypertensive agents. Before and after the erythropoietin therapy M-mode and pulsed Doppler echocardiographic studies, measurements of plasma volume by radioiodinated human...
متن کاملNo effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
BACKGROUND Ozone as a strong oxidant may induce an inflammatory response. AIM The hypothesis was verified as to whether ozonated autohemotherapy using an ozone dose in therapeutic range changes the plasma concentration of C-reactive protein and interleukin-6, markers of inflammation. METHODS In a controlled, single-blind, cross-over study, 12 chronically hemodialyzed patients with periphera...
متن کاملRelationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients
BACKGROUND microRNA (miRNA) belongs to the non-coding RNAs family responsible for the regulation of gene expression. Renalase is a protein composed of 342 amino acids, secreted by the kidneys and possibly plays an important role in the regulation of sympathetic tone and blood pressure. The aim of the present study was to investigate plasma renalase concentration, and explore the relationship be...
متن کاملDoes recombinant human erythropoietin affect plasma lipids in hemodialysis patients?
Prof. Dr. Kuddusi Cengiz, Ondokuz Mayis University School of Medicine, Department of Nephrology, TR-55139 Samsun (Turkey) Dear Sir, The correction of anemia in hemodialysis patients with human recombinant erythropoietin increases appetite, anabolic effects, and improves physical, psychological activities and endocrine functions. As the sense of well-being improves, the patients increase food in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephron
دوره 72 1 شماره
صفحات -
تاریخ انتشار 1996